Blue Jet Healthcare (Mid Cap - High Growth) Share Target 2024, 2025 To 2039
|
Blue Jet Healthcare Limited |
|||
|
Price: ₹564.25 | ||
| 52 Week Low: ₹324.00 52 Week High: ₹603.00 |
|||
| Market Capital: 9,280.37 Crore (Midcap) | |||
| Healthcare -> Biotechnology | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Blue Jet Healthcare Share Price Target For 2024
- 1.1.1: Blue Jet Healthcare Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Blue Jet Healthcare Share Price Target For 2025
- 1.2.1: Blue Jet Healthcare Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Blue Jet Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Blue Jet Healthcare Brief Company Overview
- 4: Blue Jet Healthcare Financial Performance
- 4.0.1: Is Blue Jet Healthcare A Good Buy For Long Term?
To predict the Blue Jet Healthcare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Blue Jet Healthcare Share Price Target For 2024
The line chart displays the monthly closing prices of Blue Jet Healthcare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Blue Jet Healthcare shares in 2024, see the table below.
Blue Jet Healthcare Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 602.0 (+6.69%) | Fibonacci Extension Level 100.00% |
| 2024 Target 2 | 593.86 (+5.24%) | Fibonacci Extension Level 23.60% |
| 2024 Target 1 | 587.0 (+4.03%) | Price Action: 20 Dec 2024 High |
| Current Price | 564.25 | Blue Jet Healthcare's share price as of 20 Dec 2024 |
| Stop Loss 1 | 560.4 (-0.69%) | Price Action: 20 Dec 2024 Low |
| Stop Loss 2 | 553.9 (-1.84%) | Price Action: 06 Nov 2024 High |
| Stop Loss 3 | 547.0 (-3.06%) | Fibonacci Retracement Level 50.00% |
Short-Term Technical Outlook
Current Technical Position: Blue Jet Healthcare is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹525.99 serves as the nearest technical reference point.
Historical Returns: 3-month: +11.29% | 6-month: +39.94% | 1-year: +53.58%
Blue Jet Healthcare Share Price Target For 2025
The line chart displays the monthly closing prices of Blue Jet Healthcare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Blue Jet Healthcare shares in 2025, see the table below.
Blue Jet Healthcare Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 765.92 (+35.74%) | Price Action: Chart |
| 2025 Target 2 | 751.64 (+33.21%) | Fibonacci Extension Level 64.90% |
| 2025 Target 1 | 743.56 (+31.77%) | Fibonacci Extension Level 150.00% |
| Current Price | 564.25 | Blue Jet Healthcare's share price as of 20 Dec 2024 |
| Stop Loss 1 | 525.29 (-6.91%) | Price Action: 11 Nov 2024 Low |
| Stop Loss 2 | 520.0 (-7.85%) | Price Action: 18 Nov 2024 Low |
| Stop Loss 3 | 514.1 (-8.89%) | Technical Indicator: MA50 |
Long-Term Technical Outlook
52-Week Range Analysis: Blue Jet Healthcare is currently trading near its 52-week high of ₹603, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +53.58% | 3-year: NA | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Blue Jet Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹564.25 | ||
| 2024 | ₹552.86 | -2.02% | ₹561.15 |
| 2025 | ₹756.24 | +36.79% | ₹767.58 |
| 2026 | ₹990.48 | +30.97% | ₹1,005.34 |
| 2027 | ₹1,183.31 | +19.47% | ₹1,201.06 |
| 2028 | ₹1,380.28 | +16.65% | ₹1,400.98 |
| 2029 | ₹1,599.37 | +15.87% | ₹1,623.36 |
| 2030 | ₹1,794.62 | +12.21% | ₹1,821.54 |
| 2031 | ₹2,057.48 | +14.65% | ₹2,088.34 |
| 2032 | ₹2,232.08 | +8.49% | ₹2,265.56 |
| 2033 | ₹2,419.42 | +8.39% | ₹2,455.71 |
| 2034 | ₹2,645.88 | +9.36% | ₹2,685.57 |
| 2035 | ₹2,832.99 | +7.07% | ₹2,875.48 |
| 2036 | ₹3,124.47 | +10.29% | ₹3,171.34 |
| 2037 | ₹3,280.85 | +5.01% | ₹3,330.06 |
| 2038 | ₹3,458.56 | +5.42% | ₹3,510.44 |
| 2039 | ₹3,674.95 | +6.26% | ₹3,730.07 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Blue Jet Healthcare Brief Company Overview
Blue Jet Healthcare Limited: A Comprehensive Overview Blue Jet Healthcare Limited, established in 1968, is a renowned player in the pharmaceutical industry. Key Products and Services: Pharmaceutical Intermediates Active Pharmaceutical...
Ingredients (APIs) Integrated Contrast Media Intermediates Saccharin and Related Salts CDMO/CMO and Development Services The company caters to diverse pharmaceutical and healthcare applications with its wide product range. Global Presence: Blue Jet Healthcare Limited operates globally, with a presence in countries like India, Norway, the United States, Sweden, Italy, Spain, and more. Commitment to Quality: Blue Jet Healthcare Limited is dedicated to delivering high-quality products and services to enhance healthcare outcomes.Blue Jet Healthcare Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 9,280.37 Crore | Market valuation of Blue Jet Healthcare's shares. |
| Revenue (TTM) | 721.86 Crore | Total revenue generated by Blue Jet Healthcare over the past twelve months. |
| Net Income (TTM) | +1,678,850,048.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +31.14% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +23.25% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+14.80% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+21.90% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
0.11 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1.07 Crore | Sum of Blue Jet Healthcare's current & long-term financial obligations. |
| Total Cash | 364.41 Crore | Total amount of liquid funds available to Blue Jet Healthcare. |
Is Blue Jet Healthcare A Good Buy For Long Term?
Blue Jet Healthcare, a mid-cap stock with a market capitalization of ₹9,280.37 crore, shows promising short-term performance. Its Q2 2024-25 report highlights a healthy profit margin of 23.25%, strong revenue growth (14.8% QoQ), and substantial cash reserves (₹364.41 crore) against minimal debt (₹1.07 crore). While impressive short-term returns (44.93% YTD) are noted, the lack of 3, 5, and 12-month data prevents a definitive long-term assessment. Therefore, it's currently an average buy, pending further long-term data analysis.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
